NewsBenzinga查丹资本开始覆盖 Gossamer Bio，给予买入评级，并宣布目标价为 160 美元 查丹资本开始覆盖 Gossamer Bio，给予买入评级，并宣布目标价为 160 美元 Benzinga 2026.10.13 19:31 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on PENN Entertainment, Lowers Price Target to $22 HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target Alphabet Stock Rises: What's Going On? $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today Wells Fargo Maintains Equal-Weight on MGM Resorts International, Lowers Price Target to $29 Why Is Applied Digital Stock Surging on Monday?
